Optimal Stent-Sizing With Intravascular Ultrasound Contributes to Complete Neointimal Coverage After Sirolimus-Eluting Stent Implantation Assessed by Angioscopy
Authors:
- 31 October 2009
- journal article
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 2 (10) , 989-994
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary StentsNew England Journal of Medicine, 2007
- Late Thrombosis of Drug-Eluting Stents: A Meta-Analysis of Randomized Clinical TrialsThe American Journal of Medicine, 2006
- Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting StentsJACC, 2006
- Late Angiographic Stent Thrombosis (LAST) Events With Drug-Eluting StentsJACC, 2005
- Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapyThe Lancet, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Predictors of Subacute Stent ThrombosisCirculation, 2003
- A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary RevascularizationNew England Journal of Medicine, 2002
- Stent Thrombosis in the Modern EraCirculation, 2001
- Subacute Stent Thrombosis in the Era of Intravascular Ultrasound-Guided Coronary Stenting Without Anticoagulation: Frequency, Predictors and Clinical OutcomeJACC, 1997